Alzheimer"s Disease (AD) is a progressively degenerative form of dementia in which impaired cognitive functioning is the earliest and most prominent clinical "symptom". While much has been learned about the disease process itself, progress in treatment has been slow and the search for new and more effective therapies is intensifying rapidly.This book provides a broad scientific readership with a critical assessment of the impact that the next generation of drug treatments in AD will have, based on empirical data from recent and ongoing clinical trials. Information is presented clearly and concisely, and this book will be invaluable to any researcher or clinician with an interest in AD.